secwatch.observer — SEC 8-K summary
======================================

Issuer:     ASHLAND INC. (ASH)
CIK:        0001674862
Form:       8-K
Filed at:   2026-02-02T23:59:59+00:00
Accession:  0001193125-26-033842
Event type: earnings
Sentiment:  neutral
Materiality: 0.75
Item codes: 2.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Ashland Q1 sales down 5% to $386M; narrows FY2026 EBITDA guidance to $400–420M
------------------------------------------------------------------------------

- Net loss of $12M (($0.26)/diluted share); Adjusted EPS excl. intangibles amortization $0.26.
- Adjusted EBITDA of $58M (15% margin), down 5% YoY; Avoca divestiture reduced sales ~$10M.
- Calvert City startup delay and weather disruptions caused ~$10M Adjusted EBITDA hit, isolated to Q2.
- Life Sciences grew YoY; Personal Care and Specialty Additives declined; pricing down 2%.
- Cash flow from ops $125M (including $103M tax refund); Ongoing Free Cash Flow $26M.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1674862/000119312526033842/0001193125-26-033842-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1674862/000119312526033842/ash-20260202.htm
  HTML page:      https://secwatch.observer/filing/0001193125-26-033842

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer